Atıf İçin Kopyala
Tugal-Tutkun I., Ozdal P. C.
EXPERT OPINION ON EMERGING DRUGS, cilt.25, sa.4, ss.531-547, 2020 (SCI-Expanded)
-
Yayın Türü:
Makale / Derleme
-
Cilt numarası:
25
Sayı:
4
-
Basım Tarihi:
2020
-
Doi Numarası:
10.1080/14728214.2020.1847271
-
Dergi Adı:
EXPERT OPINION ON EMERGING DRUGS
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Biotechnology Research Abstracts, EMBASE, MEDLINE
-
Sayfa Sayıları:
ss.531-547
-
Anahtar Kelimeler:
Behçet’s disease, biological, disease-modifying anti-rheumatic drug, interferon, interleukin-1 inhibitor, interleukin-6 inhibitor, retinal vasculitis, small-molecule inhibitor, tumor necrosis factor inhibitor, uveitis
-
İstanbul Üniversitesi Adresli:
Evet
Özet
Introduction: Behcet's disease uveitis (BDU) is a potentially blinding disorder. Systemic treatment with disease-modifying anti-rheumatic drugs (DMARDs) is mandatory in patients with intraocular inflammation involving the posterior segment of the eye.